全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2017 

Real-World Experiences With a Direct-Acting Antiviral Agent for Patients With Hepatitis C Virus Infection

DOI: 10.7812/TPP/16-096

Full-Text   Cite this paper   Add to My Lib

Abstract:

Traditional hepatitis C virus treatment was limited by low cure rates, side effects, and stringent monitoring requirements. Sofosbuvir, a direct-acting antiviral agent with a cure rate of 96%, was introduced in 2013. However, trials frequently excluded patients with advanced liver disease and prior treatment experience. This study aims to elucidate the real-world cure rates and sofosbuvir safety profile

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133